Annual Interest Expense
N/A
December 31, 2023
Summary
- XTLB annual interest expense is not available.
Performance
XTLB Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Interest Expense
$93.00 K
+$80.00 K+615.38%
September 30, 2024
Summary
- As of February 6, 2025, XTLB quarterly interest expense is $93.00 thousand, with the most recent change of +$80.00 thousand (+615.38%) on September 30, 2024.
- Over the past year, XTLB quarterly interest expense has increased by +$77.00 thousand (+481.25%).
- XTLB quarterly interest expense is now -90.23% below its all-time high of $952.00 thousand, reached on June 30, 2017.
Performance
XTLB Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$122.00 K
+$65.00 K+114.04%
September 30, 2024
Summary
- As of February 6, 2025, XTLB TTM interest expense is $122.00 thousand, with the most recent change of +$65.00 thousand (+114.04%) on September 30, 2024.
- Over the past year, XTLB TTM interest expense has increased by +$46.00 thousand (+60.53%).
- XTLB TTM interest expense is now -92.47% below its all-time high of $1.62 million, reached on June 30, 2017.
Performance
XTLB TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
XTLB Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +481.3% | +60.5% |
| 3 y3 years | - | +481.3% | +60.5% |
| 5 y5 years | - | - | - |
XTLB Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +4550.0% | at high | +713.3% | ||
| 5 y | 5-year | at high | +4550.0% | at high | +2950.0% | ||
| alltime | all time | -90.2% | +107.3% | -92.5% | +139.6% |
XTL Biopharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $93.00 K(+615.4%) | $122.00 K(+114.0%) |
| Jun 2024 | - | $13.00 K(-18.8%) | $57.00 K(-25.0%) |
| Mar 2024 | - | $16.00 K(-42.9%) | $76.00 K(-10.6%) |
| Sep 2023 | - | $28.00 K(-12.5%) | $85.00 K(+44.1%) |
| Jun 2023 | - | $32.00 K(+28.0%) | $59.00 K(+55.3%) |
| Mar 2023 | - | $25.00 K(+1150.0%) | $38.00 K(+72.7%) |
| Sep 2022 | - | $2000.00(-81.8%) | $22.00 K(+10.0%) |
| Jun 2022 | - | $11.00 K(+22.2%) | $20.00 K(+33.3%) |
| Mar 2022 | - | $9000.00(+50.0%) | $15.00 K(+150.0%) |
| Jun 2021 | - | $6000.00(+50.0%) | $6000.00(+50.0%) |
| Jun 2020 | - | $4000.00(-33.3%) | $4000.00(-101.3%) |
| Mar 2018 | - | $6000.00(-100.5%) | -$308.00 K(-187.3%) |
| Sep 2017 | - | -$1.27 M(-233.0%) | $353.00 K(-78.2%) |
| Jun 2017 | - | $952.00 K(+42.7%) | $1.62 M(+138.6%) |
| Mar 2017 | - | $667.00 K(>+9900.0%) | $679.00 K(+4750.0%) |
| Sep 2016 | - | $1000.00(-90.9%) | $14.00 K(-80.0%) |
| Jun 2016 | - | $11.00 K(+450.0%) | $70.00 K(+18.6%) |
| Mar 2016 | - | $2000.00(-96.5%) | $59.00 K(-19.2%) |
| Sep 2015 | - | $57.00 K(+256.3%) | $73.00 K(-17.0%) |
| Mar 2015 | - | $16.00 K(-77.8%) | $88.00 K(+14.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | - | $72.00 K(>+9900.0%) | $77.00 K(+492.3%) |
| Jun 2014 | - | $0.00(-100.0%) | $13.00 K(-18.8%) |
| Mar 2014 | - | $5000.00(-37.5%) | $16.00 K(-23.8%) |
| Sep 2013 | - | $8000.00(+166.7%) | $21.00 K(+61.5%) |
| Jun 2013 | - | $3000.00(-70.0%) | $13.00 K(-80.9%) |
| Mar 2013 | - | $10.00 K(>+9900.0%) | $68.00 K(+15.3%) |
| Sep 2012 | - | $0.00(-100.0%) | $59.00 K(-46.8%) |
| Jun 2012 | - | $58.00 K(+5700.0%) | $111.00 K(+98.2%) |
| Mar 2012 | - | $1000.00(-98.1%) | $56.00 K(-6.7%) |
| Sep 2011 | - | $52.00 K(+1633.3%) | $60.00 K(+445.5%) |
| Jun 2011 | - | $3000.00(0.0%) | $11.00 K(+22.2%) |
| Mar 2011 | - | $3000.00(+50.0%) | $9000.00(+28.6%) |
| Dec 2010 | $7000.00(-30.0%) | $2000.00(-33.3%) | $7000.00(+40.0%) |
| Sep 2010 | - | $3000.00(+200.0%) | $5000.00(+150.0%) |
| Jun 2010 | - | $1000.00(0.0%) | $2000.00(+100.0%) |
| Mar 2010 | - | $1000.00(-80.0%) | $1000.00(-90.9%) |
| Dec 2009 | $10.00 K(-41.2%) | - | - |
| Mar 2009 | - | $5000.00(+66.7%) | $11.00 K(+83.3%) |
| Dec 2008 | $17.00 K | $3000.00(0.0%) | $6000.00(+100.0%) |
| Sep 2008 | - | $3000.00 | $3000.00 |
FAQ
- What is the all time high annual interest expense for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly interest expense year-on-year change?
- What is XTL Biopharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals TTM interest expense year-on-year change?
What is the all time high annual interest expense for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual interest expense is $17.00 K
What is XTL Biopharmaceuticals quarterly interest expense?
The current quarterly interest expense of XTLB is $93.00 K
What is the all time high quarterly interest expense for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly interest expense is $952.00 K
What is XTL Biopharmaceuticals quarterly interest expense year-on-year change?
Over the past year, XTLB quarterly interest expense has changed by +$77.00 K (+481.25%)
What is XTL Biopharmaceuticals TTM interest expense?
The current TTM interest expense of XTLB is $122.00 K
What is the all time high TTM interest expense for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high TTM interest expense is $1.62 M
What is XTL Biopharmaceuticals TTM interest expense year-on-year change?
Over the past year, XTLB TTM interest expense has changed by +$46.00 K (+60.53%)